Stay updated on Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page.

Latest updates to the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check38 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed study purpose and inclusion/exclusion criteria for a clinical trial related to age-related macular degeneration, while adding new information about the study's masking procedures and a revision update.SummaryDifference20%
- Check45 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check52 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check88 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check103 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page.